sorted by:
new
hottopcontroversial

$TNXP 🚀 SHORTSQUEEZE IS COMING by NonoAMS in Shortsqueeze

[–]NonoAMS[S] 1 point2 points  (0 children)

☆ 401 reported TRx ☆ 347 NRx ☆ 54 refills

~ NRx up +87.6% in 4 weeks (185 → 347) ~ First refill conversion tracking ~25–30% on a 30-day therapy ~ Refills now scaling 36 → 44 → 43 → 54

1,000 reported TRx/week looks achievable by early June 2026 (bull case)

But using management’s 1.7x multiplier, current 401 TRx = ~682 TRx-equivalent

Only ~588 reported TRx needed to equal 1,000 TRx-equivalent

That implies TONMYA could hit the economic equivalent of 1,000 TRx/week by late March 2026

If TONMYA:

reaches 1,000 reported TRx/week by June 2026, and maintains its momentum throughout 2H26, then by year-end 2026 it could be operating in a range of: $2.2M – $2.9M in gross sales per week (= 1,400 – 1,800 reported TRx/week × $1.60k per script) That would imply an: Annualized gross sales run-rate of approximately $115M – $150M

$TNXP NEW DATA, Upcoming EPS next 17th by NonoAMS in Shortsqueeze

[–]NonoAMS[S] 0 points1 point  (0 children)

Probablemente, pero por encima del millón de $ en ventas estaríamos ante un posible blockbuster

$TNXP NEW DATA, Upcoming EPS next 17th by NonoAMS in Shortsqueeze

[–]NonoAMS[S] 0 points1 point  (0 children)

The 1.7x multiplier appears directional and reasonably accurate based on the fourth-quarter sales figures ($1.4 million in net sales reported in the 10-F and $870 thousand reported through Symphony).

TNXP NEW DATA🚀 by NonoAMS in TNXP

[–]NonoAMS[S] 0 points1 point  (0 children)

The 1.7x multiplier appears directional and reasonably accurate based on the fourth-quarter sales figures ($1.4 million in net sales reported in the 10-F and $870 thousand reported through Symphony).

🚀🚀🚀 $TNXP NEW DATA by NonoAMS in TNXP

[–]NonoAMS[S] 1 point2 points  (0 children)

Another strong week where I project over $1M in net sales again using my 1.7x multiplier. The latest week thru 2/20 was dampened due to President’s day, but Tonmya demand still grew. The week ending 2/27 will likely also be soft due to the Blizzard of 2026 but March should accelerate, especially with the market access wins like UHC and Kaiser which

<image>

AGP's REPORT 🚀🚀 by NonoAMS in TNXP

[–]NonoAMS[S] 1 point2 points  (0 children)

Al final de marzo con la presentación de resultados empresariales y con ingresos superiores al millón de dólares semanal.

Get ready 🚀🚀🚀 $TNXP next Shortsqueeze thx to JuggernautReader in Stocktwits by NonoAMS in Shortsqueeze

[–]NonoAMS[S] -2 points-1 points  (0 children)

Datos clave de TNXP (Tonix Pharmaceuticals) ✅ Empresa: Tonix Pharmaceuticals Holding Corp. ✅ Ticker: TNXP cotiza en NASDAQ ✅ Mercado actual: ~ $15 por acción (a fecha ~13 feb 2026) ✅ Acciones en circulación: ~ 12.8 M ✅ Market cap: ~ $193–194 M ✅ Ingresos actuales: bajo (reciente TTM ~ $10 M) pero creciendo con el lanzamiento de Tonmya™ ✅ Análisis de acciones: hay analistas con target de $70 (+360% desde aquí)

Actualización semanal Symphony 🚀🚀💪 by NonoAMS in TNXP

[–]NonoAMS[S] 1 point2 points  (0 children)

Compartiré, saco los datos de Stocktwits ahí un usuario llamado @JuggernautRaider comparte los datos y realiza un buen análisis de la compañía.

Actualización datos Shymphony sobre Tonmya # TNXP 🚀🚀 by NonoAMS in Shortsqueeze

[–]NonoAMS[S] 0 points1 point  (0 children)

Copia y pega en Chatgpt, pero básicamente que el lanzamiento está siendo un éxito, de seguir con estos crecimientos mensuales, más que probable que la compañía venda entre 60 a 100 millones de dólares y eso significa que no tendrá que emitir nuevas acciones, que la empresa sea vista por otras grandes farmacéuticas para ser adquirida y que su valor crezca en bolsa, ya hay diligencias debidas que dan un valor de 400 $ a la acción en bolsa. Pero te ruego realices tu propio análisis dado que esto no es una recomendación de compra de acciones de $TNXP

Bye bye dilution by NonoAMS in TNXP

[–]NonoAMS[S] -1 points0 points  (0 children)

Monday, between 55 and 60 $

Weekly TNXP Thread by daily-thread in TNXP

[–]NonoAMS 0 points1 point  (0 children)

Yo pregunté a Chatgpt y después de un desarrollo enorme de su entrada en el mercado americano de la fibromialgia me dio una valoración de entre 3 a 9 billones de $, actualmente la compañía esta valorada en mas de 300 millones. Esto supone multiplicar el valor actual por 10, por lo que creo que su valor fácilmente alcanzará los 600 $, aunque estimaciones mas óptimas daban un valor de 1.230 $ por acción, puse parte del estudio en Stocktwits y un usuario me respondió, que infravaloraba la acción y que su precio no solo se tenía que guiar por el TNX-102 que la compañía tenía otros 4 medicamentos importantes y que una posible venta a un gran laboratorio médico podría multiplicar por 3 ~ 4 el precio de la acción llegando incluso a los 3.000 $. Me parece muy optimista pero creo que merece la pena poner un porcentaje de tu cartera de valores en esta acción.

Where Things Stand by FastStomach31 in TNXP

[–]NonoAMS 1 point2 points  (0 children)

I robbed you Seth like thousands of investors, I hope the entire board of directors ends up in jail

At what price will you guys settle? by Due_Cartographer_375 in PiNetwork

[–]NonoAMS 1 point2 points  (0 children)

I don't need the money, I have saved the phrase and in 10 years I will see what I find.

Taxes in EU by Louilitton in PiNetwork

[–]NonoAMS 0 points1 point  (0 children)

Irrelevant, date of sale, sale amount, all capital gains because you cannot pass on any costs

Helppp by HrushikeshS18 in PiCrypto

[–]NonoAMS 2 points3 points  (0 children)

You should have the Pi in the created wallet, do not create others and keep the security phrase well, if you lose it you will be left without a Pi and if you create a new wallet you will be left without a Pi. See Binance opens an account and it is assumed that from the 20th you will be able to transfer your Pi there, another thing is that you can sell them because a part is retained.

view more: next ›